Houeto JL - Search Results

1

Optimal target localization for subthalamic stimulation in patients with Parkinson disease.

Welter ML, Schüpbach M, Czernecki V, Karachi C, Fernandez-Vidal S, Golmard JL, Serra G, Navarro S, Welaratne A, Hartmann A, Mesnage V, Pineau F, Cornu P, Pidoux B, Worbe Y, Zikos P, Grabli D, Galanaud D, Bonnet AM, Belaid H, Dormont D, Vidailhet M, Mallet L, Houeto JL, Bardinet E, Yelnik J, Agid Y. Welter ML, et al. Among authors: houeto jl. Neurology. 2014 Apr 15;82(15):1352-61. doi: 10.1212/WNL.0000000000000315. Epub 2014 Mar 19. Neurology. 2014. PMID: 24647024 Free PMC article.

2

Pathophysiology of Parkinson's disease.

Bonnet AM, Houeto JL. Bonnet AM, et al. Among authors: houeto jl. Biomed Pharmacother. 1999 Apr;53(3):117-21. doi: 10.1016/S0753-3322(99)80076-6. Biomed Pharmacother. 1999. PMID: 10349507 Review.

3

Subthalamic stimulation in Parkinson disease: a multidisciplinary approach.

Houeto JL, Damier P, Bejjani PB, Staedler C, Bonnet AM, Arnulf I, Pidoux B, Dormont D, Cornu P, Agid Y. Houeto JL, et al. Arch Neurol. 2000 Apr;57(4):461-5. doi: 10.1001/archneur.57.4.461. Arch Neurol. 2000. PMID: 10768618 Clinical Trial.

4

Abnormal reciprocal inhibition between antagonist muscles in Parkinson's disease.

Meunier S, Pol S, Houeto JL, Vidailhet M. Meunier S, et al. Among authors: houeto jl. Brain. 2000 May;123 ( Pt 5):1017-26. doi: 10.1093/brain/123.5.1017. Brain. 2000. PMID: 10775546

5

Levodopa-induced dyskinesias in Parkinson's disease: is sensitization reversible?

Bejjani BP, Arnulf I, Demeret S, Damier P, Bonnet AM, Houeto JL, Agid Y. Bejjani BP, et al. Among authors: houeto jl. Ann Neurol. 2000 May;47(5):655-8. Ann Neurol. 2000. PMID: 10805339

6

Neuropsychological changes between "off" and "on" STN or GPi stimulation in Parkinson's disease.

Pillon B, Ardouin C, Damier P, Krack P, Houeto JL, Klinger H, Bonnet AM, Pollak P, Benabid AL, Agid Y. Pillon B, et al. Among authors: houeto jl. Neurology. 2000 Aug 8;55(3):411-8. doi: 10.1212/wnl.55.3.411. Neurology. 2000. PMID: 10932277 Clinical Trial.

7

Failure of long-term pallidal stimulation corrected by subthalamic stimulation in PD.

Houeto JL, Bejjani PB, Damier P, Staedler C, Bonnet AM, Pidoux B, Dormont D, Cornu P, Agid Y. Houeto JL, et al. Neurology. 2000 Sep 12;55(5):728-30. doi: 10.1212/wnl.55.5.728. Neurology. 2000. PMID: 10980748

8

Improvement of sleep architecture in PD with subthalamic nucleus stimulation.

Arnulf I, Bejjani BP, Garma L, Bonnet AM, Houeto JL, Damier P, Derenne JP, Agid Y. Arnulf I, et al. Among authors: houeto jl. Neurology. 2000 Dec 12;55(11):1732-4. doi: 10.1212/wnl.55.11.1732. Neurology. 2000. PMID: 11113233

9

The role of the pallidum in Parkinson's disease gait. Lessons from pallidal stimulation.

Damier P, Houeto JL, Bejjani BP, Arnulf I, Bonnet AM, Miloudy M, Agid Y. Damier P, et al. Among authors: houeto jl. Adv Neurol. 2001;87:283-8. Adv Neurol. 2001. PMID: 11347233 Review. No abstract available.

10

Clinical predictive factors of subthalamic stimulation in Parkinson's disease.

Welter ML, Houeto JL, Tezenas du Montcel S, Mesnage V, Bonnet AM, Pillon B, Arnulf I, Pidoux B, Dormont D, Cornu P, Agid Y. Welter ML, et al. Among authors: houeto jl. Brain. 2002 Mar;125(Pt 3):575-83. doi: 10.1093/brain/awf050. Brain. 2002. PMID: 11872614

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

159 results

Search Page

Filters